Logo image of CNOBP

CONNECTONE BANCORP INC - CNOB 5 1/4 PERP (CNOBP) Stock Fundamental Analysis

USA - NASDAQ:CNOBP - US20786W5031

23.82 USD
-0.08 (-0.33%)
Last: 9/22/2025, 4:00:43 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CNOBP. CNOBP was compared to 392 industry peers in the Banks industry. CNOBP may be in some trouble as it scores bad on both profitability and health. CNOBP is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CNOBP had positive earnings in the past year.
In the past year CNOBP had a positive cash flow from operations.
CNOBP had positive earnings in each of the past 5 years.
Each year in the past 5 years CNOBP had a positive operating cash flow.
CNOBP Yearly Net Income VS EBIT VS OCF VS FCFCNOBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of CNOBP (0.23%) is worse than 85.46% of its industry peers.
CNOBP's Return On Equity of 2.09% is on the low side compared to the rest of the industry. CNOBP is outperformed by 85.46% of its industry peers.
Industry RankSector Rank
ROA 0.23%
ROE 2.09%
ROIC N/A
ROA(3y)0.91%
ROA(5y)1.05%
ROE(3y)7.4%
ROE(5y)8.27%
ROIC(3y)N/A
ROIC(5y)N/A
CNOBP Yearly ROA, ROE, ROICCNOBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of CNOBP (10.87%) is worse than 80.87% of its industry peers.
In the last couple of years the Profit Margin of CNOBP has declined.
CNOBP does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.87%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.79%
PM growth 5Y-7.42%
GM growth 3YN/A
GM growth 5YN/A
CNOBP Yearly Profit, Operating, Gross MarginsCNOBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

1

2. Health

2.1 Basic Checks

CNOBP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNOBP has less shares outstanding
Compared to 5 years ago, CNOBP has more shares outstanding
Compared to 1 year ago, CNOBP has a worse debt to assets ratio.
CNOBP Yearly Shares OutstandingCNOBP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNOBP Yearly Total Debt VS Total AssetsCNOBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CNOBP has a debt to FCF ratio of 7.82. This is a slightly negative value and a sign of low solvency as CNOBP would need 7.82 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.82, CNOBP is not doing good in the industry: 73.98% of the companies in the same industry are doing better.
CNOBP has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
CNOBP's Debt to Equity ratio of 0.18 is in line compared to the rest of the industry. CNOBP outperforms 46.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.82
Altman-Z N/A
ROIC/WACCN/A
WACC15.31%
CNOBP Yearly LT Debt VS Equity VS FCFCNOBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CNOBP Yearly Current Assets VS Current LiabilitesCNOBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.24% over the past year.
The Earnings Per Share has been decreasing by -4.32% on average over the past years.
CNOBP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.09%.
CNOBP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.33% yearly.
EPS 1Y (TTM)9.24%
EPS 3Y-17.32%
EPS 5Y-4.32%
EPS Q2Q%19.57%
Revenue 1Y (TTM)10.09%
Revenue growth 3Y-1.77%
Revenue growth 5Y6.33%
Sales Q2Q%28.39%

3.2 Future

Based on estimates for the next years, CNOBP will show a very strong growth in Earnings Per Share. The EPS will grow by 33.89% on average per year.
CNOBP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.34% yearly.
EPS Next Y37.63%
EPS Next 2Y33.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.89%
Revenue Next 2Y38.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNOBP Yearly Revenue VS EstimatesCNOBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
CNOBP Yearly EPS VS EstimatesCNOBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.85, the valuation of CNOBP can be described as reasonable.
61.22% of the companies in the same industry are more expensive than CNOBP, based on the Price/Earnings ratio.
CNOBP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 7.30 indicates a rather cheap valuation of CNOBP.
90.05% of the companies in the same industry are more expensive than CNOBP, based on the Price/Forward Earnings ratio.
CNOBP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.85
Fwd PE 7.3
CNOBP Price Earnings VS Forward Price EarningsCNOBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNOBP indicates a slightly more expensive valuation: CNOBP is more expensive than 77.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 33.86
EV/EBITDA N/A
CNOBP Per share dataCNOBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CNOBP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CNOBP's earnings are expected to grow with 33.89% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y33.89%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CNOBP has a Yearly Dividend Yield of 2.74%. Purely for dividend investing, there may be better candidates out there.
CNOBP's Dividend Yield is comparable with the industry average which is at 3.47.
Compared to an average S&P500 Dividend Yield of 2.38, CNOBP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

The dividend of CNOBP is nicely growing with an annual growth rate of 19.08%!
CNOBP has been paying a dividend for over 5 years, so it has already some track record.
CNOBP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)19.08%
Div Incr Years0
Div Non Decr Years3
CNOBP Yearly Dividends per shareCNOBP Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CNOBP pays out 107.52% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CNOBP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP107.52%
EPS Next 2Y33.89%
EPS Next 3YN/A
CNOBP Yearly Income VS Free CF VS DividendCNOBP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CNOBP Dividend Payout.CNOBP Dividend Payout, showing the Payout Ratio.CNOBP Dividend Payout.PayoutRetained Earnings

More info and screens

CONNECTONE BANCORP INC - CNOB 5 1/4 PERP

NASDAQ:CNOBP (9/22/2025, 4:00:43 PM)

23.82

-0.08 (-0.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22/bmo
Inst Owners57.38%
Inst Owner ChangeN/A
Ins Owners3.41%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts86
Price Target27.8 (16.71%)
Short Float %0.02%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend0.87
Dividend Growth(5Y)19.08%
DP107.52%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-15 2025-08-15 (0.328125)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.73%
Min EPS beat(2)-1.24%
Max EPS beat(2)8.7%
EPS beat(4)2
Avg EPS beat(4)5.27%
Min EPS beat(4)-4.46%
Max EPS beat(4)18.1%
EPS beat(8)5
Avg EPS beat(8)3.41%
EPS beat(12)6
Avg EPS beat(12)0.11%
EPS beat(16)9
Avg EPS beat(16)0.61%
Revenue beat(2)1
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)3.36%
Revenue beat(4)1
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-6.06%
Max Revenue beat(4)3.36%
Revenue beat(8)1
Avg Revenue beat(8)-2.72%
Revenue beat(12)2
Avg Revenue beat(12)-2.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.68%
PT rev (1m)-10.43%
PT rev (3m)-9.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)3.44%
Valuation
Industry RankSector Rank
PE 11.85
Fwd PE 7.3
P/S 4.15
P/FCF 33.86
P/OCF 30.52
P/B 0.8
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)2.01
EY8.44%
EPS(NY)3.26
Fwd EY13.7%
FCF(TTM)0.7
FCFY2.95%
OCF(TTM)0.78
OCFY3.28%
SpS5.74
BVpS29.77
TBVpS24.16
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.23%
ROE 2.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.87%
GM N/A
FCFM 12.27%
ROA(3y)0.91%
ROA(5y)1.05%
ROE(3y)7.4%
ROE(5y)8.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.79%
PM growth 5Y-7.42%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.82
Debt/EBITDA N/A
Cap/Depr 56.92%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 112.82%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC15.31%
ROIC/WACCN/A
Cap/Depr(3y)83.7%
Cap/Depr(5y)66.34%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.42%
Profit Quality(3y)111.87%
Profit Quality(5y)120.48%
High Growth Momentum
Growth
EPS 1Y (TTM)9.24%
EPS 3Y-17.32%
EPS 5Y-4.32%
EPS Q2Q%19.57%
EPS Next Y37.63%
EPS Next 2Y33.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.09%
Revenue growth 3Y-1.77%
Revenue growth 5Y6.33%
Sales Q2Q%28.39%
Revenue Next Year48.89%
Revenue Next 2Y38.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-74.35%
FCF growth 3Y-34.17%
FCF growth 5Y-0.79%
OCF growth 1Y-72.64%
OCF growth 3Y-33.05%
OCF growth 5Y0%